Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.03 USD | +0.53% | +7.46% | -23.56% |
05-07 | Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M | MT |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.56% | 1.6B | |
-16.96% | 11.65B | |
-30.43% | 2.33B | |
-11.81% | 2.2B | |
+36.79% | 1.2B | |
-3.28% | 758M | |
-12.67% | 529M | |
-36.53% | 475M | |
+13.72% | 338M | |
+14.89% | 227M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Veracyte : Partners With Bayer for Thyroid Cancer Program; Shares Climb